Selectively N-protected enantiopure 2,5-disubstituted piperazines: Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Selectively N-protected enantiopure 2,5-disubstituted piperazines : Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations. / Ottesen, Lars Korsgaard; Olsen, Christian Adam; Witt, Matthias; Jaroszewski, Jerzy Witold; Franzyk, Henrik.

In: Chemistry: A European Journal, Vol. 15, No. 12, 2009, p. 2966-2978.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Ottesen, LK, Olsen, CA, Witt, M, Jaroszewski, JW & Franzyk, H 2009, 'Selectively N-protected enantiopure 2,5-disubstituted piperazines: Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations', Chemistry: A European Journal, vol. 15, no. 12, pp. 2966-2978. https://doi.org/10.1002/chem.200802044

APA

Ottesen, L. K., Olsen, C. A., Witt, M., Jaroszewski, J. W., & Franzyk, H. (2009). Selectively N-protected enantiopure 2,5-disubstituted piperazines: Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations. Chemistry: A European Journal, 15(12), 2966-2978. https://doi.org/10.1002/chem.200802044

Vancouver

Ottesen LK, Olsen CA, Witt M, Jaroszewski JW, Franzyk H. Selectively N-protected enantiopure 2,5-disubstituted piperazines: Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations. Chemistry: A European Journal. 2009;15(12):2966-2978. https://doi.org/10.1002/chem.200802044

Author

Ottesen, Lars Korsgaard ; Olsen, Christian Adam ; Witt, Matthias ; Jaroszewski, Jerzy Witold ; Franzyk, Henrik. / Selectively N-protected enantiopure 2,5-disubstituted piperazines : Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations. In: Chemistry: A European Journal. 2009 ; Vol. 15, No. 12. pp. 2966-2978.

Bibtex

@article{d6d528b0f74911ddbf70000ea68e967b,
title = "Selectively N-protected enantiopure 2,5-disubstituted piperazines: Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations",
abstract = "An efficient solid-phase route to ring-substituted piperazines from O-linked resin-bound (S)-aziridine-2-methanol is described. Regioselective microwave-assisted aminolysis followed by intramolecular Fukuyama-Mitsunobu cyclization constitute the key features of the protocol. Simple piperazines and diazepanes were readily obtained without preceding N-protection of the acyclic intermediate, whereas attempts to extend this protocol to chiral 2,5-disubstituted piperazines failed. Modifications encompassing N-carbamoylation prior to ring-closure were therefore investigated. However, standard carbamoylating agents, for example, Fmoc-Cl and Alloc-Cl tended to give bis-protected by-products. Thus, novel microwave-assisted solid-phase N-protection procedures were developed for efficient introduction of Fmoc, Boc and Alloc groups. The subsequent cyclization proceeded in moderate to excellent yields depending on the bulk of the side chain and type of N-protecting group. This protocol readily provided novel cis- and trans-2,5-disubstituted piperazines displaying a variety of N-protecting group patterns after further on-resin manipulations. Also, unexpected by-products obtained during these optimization studies were identified and characterized. This includes nosylated ureas arising from an alternative cyclization pathway. Finally, post-cleavage oxidation gave access to the Fmoc/Boc-protected alpha-amino acid as well as the corresponding aldehyde. The chiral piperazines described in this work will enable construction of combinatorial libraries with a higher chemical diversity compared to those containing simple N,N'-difunctionalized piperazines, often present in drug-like compounds.",
keywords = "Former Faculty of Pharmaceutical Sciences",
author = "Ottesen, {Lars Korsgaard} and Olsen, {Christian Adam} and Matthias Witt and Jaroszewski, {Jerzy Witold} and Henrik Franzyk",
note = "Keywords: aminolysis; aziridines; Fukuyama-Mitsunobu cyclization; piperazines; solid-phase synthesis",
year = "2009",
doi = "10.1002/chem.200802044",
language = "English",
volume = "15",
pages = "2966--2978",
journal = "Chemistry: A European Journal",
issn = "0947-6539",
publisher = "Wiley - V C H Verlag GmbH & Co. KGaA",
number = "12",

}

RIS

TY - JOUR

T1 - Selectively N-protected enantiopure 2,5-disubstituted piperazines

T2 - Avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations

AU - Ottesen, Lars Korsgaard

AU - Olsen, Christian Adam

AU - Witt, Matthias

AU - Jaroszewski, Jerzy Witold

AU - Franzyk, Henrik

N1 - Keywords: aminolysis; aziridines; Fukuyama-Mitsunobu cyclization; piperazines; solid-phase synthesis

PY - 2009

Y1 - 2009

N2 - An efficient solid-phase route to ring-substituted piperazines from O-linked resin-bound (S)-aziridine-2-methanol is described. Regioselective microwave-assisted aminolysis followed by intramolecular Fukuyama-Mitsunobu cyclization constitute the key features of the protocol. Simple piperazines and diazepanes were readily obtained without preceding N-protection of the acyclic intermediate, whereas attempts to extend this protocol to chiral 2,5-disubstituted piperazines failed. Modifications encompassing N-carbamoylation prior to ring-closure were therefore investigated. However, standard carbamoylating agents, for example, Fmoc-Cl and Alloc-Cl tended to give bis-protected by-products. Thus, novel microwave-assisted solid-phase N-protection procedures were developed for efficient introduction of Fmoc, Boc and Alloc groups. The subsequent cyclization proceeded in moderate to excellent yields depending on the bulk of the side chain and type of N-protecting group. This protocol readily provided novel cis- and trans-2,5-disubstituted piperazines displaying a variety of N-protecting group patterns after further on-resin manipulations. Also, unexpected by-products obtained during these optimization studies were identified and characterized. This includes nosylated ureas arising from an alternative cyclization pathway. Finally, post-cleavage oxidation gave access to the Fmoc/Boc-protected alpha-amino acid as well as the corresponding aldehyde. The chiral piperazines described in this work will enable construction of combinatorial libraries with a higher chemical diversity compared to those containing simple N,N'-difunctionalized piperazines, often present in drug-like compounds.

AB - An efficient solid-phase route to ring-substituted piperazines from O-linked resin-bound (S)-aziridine-2-methanol is described. Regioselective microwave-assisted aminolysis followed by intramolecular Fukuyama-Mitsunobu cyclization constitute the key features of the protocol. Simple piperazines and diazepanes were readily obtained without preceding N-protection of the acyclic intermediate, whereas attempts to extend this protocol to chiral 2,5-disubstituted piperazines failed. Modifications encompassing N-carbamoylation prior to ring-closure were therefore investigated. However, standard carbamoylating agents, for example, Fmoc-Cl and Alloc-Cl tended to give bis-protected by-products. Thus, novel microwave-assisted solid-phase N-protection procedures were developed for efficient introduction of Fmoc, Boc and Alloc groups. The subsequent cyclization proceeded in moderate to excellent yields depending on the bulk of the side chain and type of N-protecting group. This protocol readily provided novel cis- and trans-2,5-disubstituted piperazines displaying a variety of N-protecting group patterns after further on-resin manipulations. Also, unexpected by-products obtained during these optimization studies were identified and characterized. This includes nosylated ureas arising from an alternative cyclization pathway. Finally, post-cleavage oxidation gave access to the Fmoc/Boc-protected alpha-amino acid as well as the corresponding aldehyde. The chiral piperazines described in this work will enable construction of combinatorial libraries with a higher chemical diversity compared to those containing simple N,N'-difunctionalized piperazines, often present in drug-like compounds.

KW - Former Faculty of Pharmaceutical Sciences

U2 - 10.1002/chem.200802044

DO - 10.1002/chem.200802044

M3 - Journal article

C2 - 19191236

VL - 15

SP - 2966

EP - 2978

JO - Chemistry: A European Journal

JF - Chemistry: A European Journal

SN - 0947-6539

IS - 12

ER -

ID: 10240897